工具
选股器
从StockVane跟踪的3753只美股大盘股中筛选,并可按任意列排序。结果中的量化评级与个股页面上显示的一致。
176 个匹配结果
| 公司 | 60日 | 最新价 | 涨跌幅 | 市值 | 市盈率 | 股息率 | 近一年 | 量化评级 ↓ |
|---|---|---|---|---|---|---|---|---|
| Adlai Nortye GroupANL | 11.03 | -8.77% | $710.31M | -- | -- | +572.6% | A 100 | |
| Climb BioCLYM | 9.82 | -9.99% | $564.02M | -- | -- | +408.8% | D 100 | |
| ModernaMRNA | 218.01 | -7.82% | $87.04B | -- | -- | +738.2% | A 100 | |
| Praxis Precision MedicinesPRAX | 241.76 | -2.61% | $6.75B | -- | -- | +27.2% | D 100 | |
| Iovance BiotherapeuticsIOVA | 13.62 | -7.47% | $6.17B | -- | -- | +524.8% | A 100 | |
| Kodiak SciencesKOD | 85.75 | -2.69% | $5.39B | -- | -- | +508.2% | A 100 | |
| ErascaERAS | 13.39 | -9.95% | $4.68B | -- | -- | +453.3% | D 100 | |
| Sellas Life SciencesSLS | 9.98 | -11.99% | $2.02B | -- | -- | +366.4% | B 100 | |
| Alto NeuroscienceANRO | 21.94 | -3.01% | $860.97M | -- | -- | +260.9% | D 99 | |
| Immix BiopharmaIMMX | 7.98 | -8.06% | $662.97M | -- | -- | +178.0% | D 99 | |
| Nuvectis PharmaNVCT | 18.60 | -1.74% | $607.18M | -- | -- | +201.5% | B 99 | |
| Shattuck LabsSTTK | 5.42 | -1.99% | $543.97M | -- | -- | +199.4% | D 99 | |
| Revolution MedicinesRVMD | 177.96 | -5.97% | $38.14B | -- | -- | +228.9% | B 99 | |
| ImmunityBioIBRX | 9.18 | -8.20% | $9.73B | -- | -- | +282.5% | B 99 | |
| Spyre TherapeuticsSYRE | 79.90 | -0.25% | $7.37B | -- | -- | +255.6% | B 99 | |
| MBX BiosciencesMBX | 49.61 | -2.17% | $2.39B | -- | -- | +275.3% | B 99 | |
| OmniAbOABI | 4.59 | -2.96% | $667.34M | -- | -- | +176.5% | B 98 | |
| Relay TherapeuticsRLAY | 16.28 | -5.90% | $3.57B | -- | -- | +150.8% | B 98 | |
| Inhibrx BiosciencesINBX | 89.83 | -0.74% | $1.32B | -- | -- | +141.2% | D 98 | |
| Tango TherapeuticsTNGX | 22.04 | -2.91% | $3.72B | -- | -- | +144.1% | B 97 | |
| Nurix TherapeuticsNRIX | 24.42 | -2.12% | $2.67B | 10.05 | -- | +148.2% | B 97 | |
| Fortrea HoldingsFTRE | 22.49 | -1.12% | $2.14B | -- | -- | +138.0% | B 97 | |
| ReplimuneREPL | 10.86 | -7.57% | $1.02B | -- | -- | +141.3% | B 97 | |
| Roivant SciencesROIV | 33.53 | -1.50% | $24.22B | -- | -- | +94.3% | B 95 | |
| Dianthus TherapeuticsDNTH | 72.09 | -3.27% | $4.03B | -- | -- | +102.2% | D 95 | |
| UroGen Pharma LtdURGN | 34.56 | -5.60% | $1.69B | -- | -- | +103.9% | B 95 | |
| Korsana BiosciencesKRSA | 32.38 | -3.77% | $1.47B | -- | -- | +106.5% | B 95 | |
| Maravai LifeSciencesMRVI | 6.79 | -3.96% | $1.01B | -- | -- | +105.8% | B 95 | |
| Halozyme TherapeuticsHALO | 121.84 | +0.27% | $13.83B | 35.73 | -- | +81.8% | B 93 | |
| Travere TherapeuticTVTX | 49.60 | -6.04% | $4.68B | -- | -- | +81.6% | B 93 | |
| Puma BiotechnologyPBYI | 9.83 | -6.56% | $507.43M | 19.27 | -- | +79.7% | B 92 | |
| Cogent BiosciencesCOGT | 29.52 | +0.03% | $5.12B | -- | -- | +80.1% | D 92 | |
| PrecigenPGEN | 6.39 | -11.26% | $2.29B | -- | -- | +59.6% | B 92 | |
| Royalty PharmaRPRX | 60.96 | +2.25% | $27.14B | 32.77 | 1.49% | +67.9% | B 91 | |
| Aclaris TherapeuticsACRS | 3.28 | -6.02% | $482.81M | -- | -- | +72.6% | D 90 | |
| CybinHELP | 10.55 | -4.52% | $770.78M | -- | -- | +75.0% | B 90 | |
| Kymera TherapeuticsKYMR | 104.78 | -3.11% | $8.71B | -- | -- | +75.1% | B 90 | |
| Rigel PharmaceuticalsRIGL | 45.97 | -2.71% | $858.71M | 2.72 | -- | +64.5% | B 89 | |
| Krystal BiotechKRYS | 316.58 | -4.07% | $9.37B | 39.67 | -- | +66.4% | B 89 | |
| Protagonist TherapeuticsPTGX | 128.75 | -5.71% | $8.33B | 125.00 | -- | +66.1% | B 89 | |
| Absci CorpABSI | 8.25 | -7.09% | $1.42B | -- | -- | +82.1% | B 89 | |
| Vir BiotechnologyVIR | 9.96 | -4.87% | $1.69B | -- | -- | +72.3% | B 89 | |
| XencorXNCR | 22.85 | -4.79% | $1.70B | -- | -- | +54.7% | B 89 | |
| Ligand PharmaceuticalsLGND | 295.54 | -0.99% | $5.89B | 30.44 | -- | +62.7% | B 88 | |
| Damora TherapeuticsDMRA | 18.44 | -1.60% | $1.14B | -- | -- | +92.5% | D 87 | |
| Jazz PharmaceuticalsJAZZ | 210.23 | -1.95% | $13.65B | 14.39 | -- | +54.5% | D 86 | |
| ExelixisEXEL | 62.23 | -0.96% | $15.42B | 19.57 | -- | +58.5% | B 86 | |
| OmerosOMER | 16.20 | -13.78% | $1.17B | 9.36 | -- | +99.8% | B 86 | |
| Design TherapeuticsDSGN | 10.31 | -1.62% | $645.22M | -- | -- | +79.6% | D 85 | |
| TG TherapeuticsTGTX | 53.97 | -3.63% | $8.26B | 19.70 | -- | +55.7% | B 85 | |
| Cullinan TherapeuticsCGEM | 12.93 | -7.64% | $832.11M | -- | -- | +64.6% | D 84 | |
| ImmunovantIMVT | 26.73 | -2.84% | $5.52B | -- | -- | +52.7% | D 83 | |
| Arrowhead PharmaceuticalsARWR | 55.90 | -4.44% | $7.90B | -- | -- | +51.9% | D 82 | |
| VaxcytePCVX | 63.62 | -2.53% | $10.01B | -- | -- | +50.1% | B 81 | |
| Corcept TherapeuticsCORT | 110.16 | -2.83% | $11.91B | 244.80 | -- | +40.0% | B 80 | |
| Harmony BiosciencesHRMY | 37.95 | -0.84% | $2.21B | 12.28 | -- | +46.5% | B 80 | |
| Aurinia PharmaceuticalsAUPH | 16.51 | -1.32% | $2.20B | 7.24 | -- | +42.9% | B 80 | |
| CG OncologyCGON | 59.85 | -3.25% | $5.31B | -- | -- | +44.4% | D 78 | |
| Faeth TherapeuticsFTH | 18.80 | -8.74% | $485.80M | -- | -- | +60.7% | D 77 | |
| Regeneron PharmaceuticalsREGN | 790.74 | -0.70% | $81.41B | 19.57 | 0.46% | +37.5% | B 77 |
仅供参考,不构成投资建议。筛选结果是研究的起点,而非买入清单。量化评级方法详见数据与方法说明。